Inhibition of glycolysis disrupts cellular antioxidant defense and sensitizes HepG2 cells to doxorubicin treatment
Agnieszka Korga-Plewko(Medical University of Lublin), Jarosław Dudka(Medical University of Lublin), Magdalena Iwan(Medical University of Lublin), Mariola Herbet(Medical University of Lublin), Marta Ostrowska-Leśko(Medical University of Lublin)
Cited by 50
Related Papers
HPA Axis in the Pathomechanism of Depression and Schizophrenia: New Therapeutic Strategies Based on Its Participation
|Brain Sciences|2021|399
Inflammatory Processes in Alzheimer’s Disease—Pathomechanism, Diagnosis and Treatment: A Review
|International Journal of Molecular Sciences|2023|327
Apigenin and hesperidin augment the toxic effect of doxorubicin against HepG2 cells
|BMC Pharmacology and Toxicology|2019|61
The effect of a number of H9C2 rat cardiomyocytes passage on repeatability of cytotoxicity study results
|Cytotechnology|2016|48
The Role of Molecular and Inflammatory Indicators in the Assessment of Cognitive Dysfunction in a Mouse Model of Diabetes
|International Journal of Molecular Sciences|2021|43